chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the vaccine on 6/25 at 10am. By 5pm I had severe body aches and a fever temperature of 100.8. That night I suffered from severe insomnia along with severe shaking, body aches and a 102 degree fever. I took extra strength Tylenol and used cold packs to attempt to reduce my fevers. The symptoms and 102 fever lasted throughout 6/26 at several times I contemplated going to the emergency room since the fever was high. My body aches were so bad and my entire body was tightening up causing extreme muscle and joint soreness. During the early morning hours of 6/27 my fever finally broke and I began sweating profusely. I would sweat and have a hot flash like event occur throughout the day. I also felt very foggy and my energy levels were extremely low. I did not feel better until 6/28. For the record I had already had the covid virus and my last blood work up (approx 3 months prior) from my physician showed high levels of antibodies.
I performed a mild workout 30 minutes prior to the start of symptoms. I started to feel moderate body aches in my back and sides, felt flush and very tired and heavy. Temperature rose to 99.3.  Symptoms began to subside after about 4 hours and temperature came down to a normal 98.3.
Tightness on the middle of his chest and a sharp pain; Tightness on the middle of his chest and a sharp pain; Injection site pain; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE PAIN (Injection site pain), CHEST DISCOMFORT (Tightness on the middle of his chest and a sharp pain) and CHEST PAIN (Tightness on the middle of his chest and a sharp pain) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain). On 13-Jan-2021, the patient experienced CHEST DISCOMFORT (Tightness on the middle of his chest and a sharp pain) and CHEST PAIN (Tightness on the middle of his chest and a sharp pain). At the time of the report, VACCINATION SITE PAIN (Injection site pain), CHEST DISCOMFORT (Tightness on the middle of his chest and a sharp pain) and CHEST PAIN (Tightness on the middle of his chest and a sharp pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Developed temp 1/4/13 up to 102.6 x 2 days, temp 99-100 additional 4 days, headache and aches in neck & throat.
This female subject was enrolled in non-GSK study. Medical conditions at the time of the event included seizure disorder. Concomitant medications included Phenobarbital and Dilantin. On 29 August 2003, one day after a dose of ENGERIX B, one day after a dose of DAPTACEL, one day after a dose of IPOL, one day after a dose of ACTHIB, one day after a dose of PREVNAR, this seven-month-old subject developed seizure and fever. The subject was hospitalised. Outcome was unknown at the time of reporting. The investigator reported the fever as possibly related to ENGERIX B, DAPTACEL, IPOL, ACTHIB and PREVNAR and that the events were possibly due to medical condition. The seizure disorder was determined as congenital and unrelated. The subject had suffered from seizures since birth (23 January 2009) which were controlled with phenobarbital and Dilantin. Her seizures were described as the subject turning red, giving a loud scream, jerking and stiffness which would last two to three minutes. On 09 July 2003 the subject had a neurology visit. During the visit it was noted that a recent EEG showed a relatively benign background, with photic driving on the left side and not on the right, suggesting an asymmetry of the occipital lobe function on one side, possibly on the right. Developmentally at 6 months she had a high pitch cry as her mode of communication but had some babbling sounds emerging. She was not yet sitting up on her own, but would lie on her stomach and push herself into a V shape with her feet on the floor and then arch herself forward. Exam showed a weight of 7.35 kg, height of 25 inches, head circumference 16.5 inches. Neurological exam showed an alert, happy, interactive child. Facial movement was strong and symmetric. Motor examination showed relatively normal bulk, tone, and strength. MRI to be scheduled later that month and a referral was recommended due to the risk of developmental delays. In addition, hearing and ophthalmology screening tests will be performed due to risk in sensory areas. One day post vaccination, on 29 August 2003, the subject presented with a fever and a change in mental status and was admitted to the hospital. The subject had a spinal tap which was negative and a CT scan of the brain which was normal. Her medication was adjusted and she did well, returning to baseline managed seizure disorder. The subject was discharged on 30 August 2003. On 29 October 2003 the subject had a neurology consultation. The subject continued to make excellent developmental progress and had been weaned off Dilantin. At that time the subject was taking on phenobarbital 4 ml twice a day. Upon assessment, her weight was 8.15 Kg, height was 28 inches, head circumference 17 1/4 inches. Developmentally she was bearing weight, sitting independently, had a pincer grasp bilaterally, and reaching for objects. Impression included normal developmental examination. Follow up was recommended in three to six months.
Parents brought child back into office within a half hour of immunization. Child had huge (6 cm in duration) on leg of HIB vaccine. Benadryl 12.5 po, ice pack, and Tylenol. Gave Benadryl through the night.
Initial lightheadedness/dizziness/tiredness after injection for about two hours. Next day: Red spot appeared on arm. Slowly grew in size over the course of two days to 3" diameter and about 1/4" high.
Patient is complaining of spasms in her back, claims to have had no symptoms after 1st 2 vaccinations but experienced the spasms after her booster dose.
Pain in (L) neck and (L) upper shoulder area; developed weakness of (L) arm resolving symptoms developed within a few wks of flu administration.
Left arm. Large, red swollen, hot, indurated, itchy. Almost 1/2 length of left upper arm.
Developed rash all over body 4 hours after receiving vaccine.  Was taken to urgent car, rapid strep test done to rule out scarlet fever.  Rapid strep test negative.  Visited with Dermatology specialist who confirmed adverse reaction to Hepatitis B vaccine.
Patient fully vaccinated (Moderna), but not boosted, admitted to the hospital on 1/7/22 with COVID-19 and associated hypoxia. Patient was discharged on 1/14/22.
The arm was achy; This is a spontaneous report from a contactable consumer (patient).  A 72-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (tradename unspecified, lot/batch number was unknown) solution for injection in pre-filled syringe, via an unspecified route of administration on an unspecified date at a single dose for pneumonia; influenza vaccine (FLU) , via an unspecified route of administration in Oct2020 at a single dose for influenza. Medical history included breast cancer, hypertension, hiatal hernia, and glaucoma. The patient's concomitant medications were not reported. The patient reported she has had no issues with vaccines in the past. She had pneumonia and flu vaccine. She reported that her arm was achy, but she doesn't remember anything like lymph nodes, feet, or legs having symptoms. She got a Flu Vaccine at work in Oct2020. She got the Pneumonia vaccine at the doctor's office, she does not know when, unknown, but maybe in the last 5-3 years. Outcome of the event was unknown.  Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) has submitted the same report to the regulatory authorities.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Fever 100F after 1st Prevnar immunization, Temp >102F after 2nd Prevnar.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 10-JUN-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) lot # K025766,  expiry date 08-JUN-2015. This is one of the several reports received from the same reporter. Additional information has been requested.
With first injection, only had injection site soreness; This case was reported by a consumer and described the occurrence of injection site pain in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced injection site soreness with 1st dose. For tolerance to 2nd dose refer linked case US2020034250, reported by the same reporter. ; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR218281:same patient
3/11 few hours after vaccine given c/o faintness/abd pain/feeling "weird". PE - alert oriented pale color, "lightheaded"; abd exam nl. Phone f/u next AM mother states feeling better, some abd discomfort, no D/V. Went to school.
This spontaneous case, was initially received on 27-Oct-2017 from a pharmacist, concerns a 03-year-old female child patient. The patient's medical history and concomitant medications were not reported. On 27-Oct-2017, the patient was administered with FLUCELVAX (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 195238, expiry date: 31-May-2018). It was reported that, 3.5-year-old patient was administered with the vaccine (explicitly coded as inappropriate age at vaccine administration) and was observed for 30 minutes. No adverse reactions had occurred. The reporter assessed the report as non-serious. Significant case correction received with IRD 27-OCT-2017: The event "no adverse event" was deleted and expiry date of the product (31-May-2017) was corrected and narrative amended accordingly.
Patient was with cousin overnight, who had chicken pox, at the end of Feb 2005.  About 3 weeks later patient complained of being itchy at school.  Patient had a total of 15 pox.  Physician consulted, no diagnostic tests performed.
Injection site was very red(3 inch diameter area), hard, hot and itchy. This reaction went away in about 2 days.  Then on 3/6/21 there was a smaller, less red area below the injection site closer to my elbow. This was just itchy and was gone within a day.
Severe chills; Nausea; High fever; Body ache; Dizziness; This is a spontaneous report from a contactable consumer. A male patient of unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 30Apr2021, the patient experienced severe chills, nausea, body ache and dizziness. On 30Apr2021 night, the patient experienced high fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the event's severe chills, nausea, body ache and dizziness was resolved on an unknown date in 2021 and high fever was resolved by 03May2021 night.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning an otherwise healthy 2 month old patient product of a full term deliver who on approximately 27 Sep 2006 was vaccinated with the first dose of Rotateq (human bovine). Concomitant vaccinations administered on that same day included a dose of Dtap, a dose of poliovirus vaccine inactivated (unspecified), a dose of PedVax Hib and a dose of Recombivax HB. There was no other concomitant therapy. The physician reported that on approximately 27 Sep 2006, 'right after vaccine, the patient developed watery, voluminous, non bloody stool characterized by 12-14 stools per day and fever. The patients fever initially resolved, but had since restarted. The physician also reported that the patient had occasional vomiting after feeding described as "spitting up". The patient had no upper respiratory symptoms and no rash. It was noted that the patient had no ill contacts or contacts with iguanas, turtles, and no recent travel. There was no family history of immunocompromise. It was unknown if the patient attended daycare. The patient was feeding on Isomil and had good urine output. Unspecified medical attention was sought. A stool sample was sent for culture and was negative for salmonella, shigella, campylobacter and E. coli. At the time of this report, the patient's fever persisted and the diarrhea had lasted for greater than 14 days. The outcome of the patient's vomiting was unknown. Additional information has been requested.
Soreness at injection site began about 4 hours after injection.  It had subsided by two days later but still sore to the touch.  Aches and fever began about 4 hours after injection but was controllable with ibuprofen.  Fever peaked about 30 hours after injection at 99.2 degrees.  My normal temperature is around 97.5  so 1.5-degree above is very noticeable.  Fever broke about 36 hours after injection.
I was unresponsive, he could not wake me up; Had pain in my neck on the same site of the shot; Had pain in my neck on the same site of the shot.; Nerve pain; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), first dose via an unspecified route of administration, administered in left deltoid (left arm) on 17May2021 (at the age of 60-year-old, Batch/Lot Number: EW0177) as a single dose for Covid-19 immunization. Medical history included the patient had a child arrhythmia; she believed it was from 1996 but it pretty much controlled and prior to vaccine. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. This report was not related to a study or programme. The patient stated that she had a concern because she took the first COVID vaccine on the 17May2021 and she was due to get the second one on the 07Jun2021 however she had some concern today. The patient stated that she had some changed episode of reactions on 17May2021, she started having pain, after she took the first one, on the same day, she had pain in her neck on the same site of the shot and had some effect of pain, a nerve pain and it had devastated to the back of her neck where she had her thick neck and she had to use warm pack on the back of my neck. It would be about 4'O clock in the morning which would be on the 18May2021 her husband was observing her because he is a nurse and he could not wake her up, he tried everything possible to wake her up and he attempted to perform cardiopulmonary resuscitation (CPR) on her, so she was concerned about putting herself again such an event taken place. The patient went to the emergency room. They took her to the emergency room however she got her name administered in 'first a clinic' and he was able to stabilize her. The patient went to the emergency room and when she got there it was like a concerning so when she got there, she was not seen by the doctor because she was feeling little better but the context person, and they did concern that some of the episode she had, she saw the effect after COVID vaccine, she was concerned because she was due for the second vaccine and this was the first episode which she had, and she was concerned whether not should, she take the second shot, she went on her and she reported. The patient could not get this anyone, all she got was the worst. They took her to late but whatever she never got a chance to speak with anyone in her life, you know she do consult with her doctor has followed her so she was concerned now that she would have a second shot, she did not know if she could really take it. When concern confirmed the patient stated that she did have adverse reactions to the Covid-19 shot. The outcome of the events was recovering.  Information on Lot/Batch number was available. Additional information has been requested.
Bleeding on the toe of foot.    Complete sock from ball of foot  to end  of ties was soaked with blood.   This was a spot that Would bleed when I had IV chemo therapy in 2012. Called Dr. And HHT. Clinic at Hospital
Patient got Moderna for her first dose and was supposed to get a second dose of Moderna.  Patient received Pfizer rather than Moderna.
Information has been received from a physician concerning a 7 month old male with no allergies or medical history who on 16-Dec-2005 was vaccinated SC with a 0.5ml dose of hepatitis B virus vaccine rHBsAg (yeast). There was no concomitant medication. On 17-Dec-2005, about 24 hours post vaccination, the patient developed thousands of morbilliform papular eruptions of his entire body. No other symptoms were noted. No lab diagnostics were performed and at the time of the report the patient was recovering. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
pt recv vax & w/in 12hr p/vax pt exp chest pain & hives;
Fever between 99.5-100+ every day since vaccine administered 11/6/09. Malaise with fever, achy, headaches for 1 week starting 4 or 5 days after. Pharyngitis-2 days after. Treating with acetaminophen and ibuprofen.
2 INCH CIRCLE THAT IS DARKER WHERE THE VACCINE WAS GIVEN; INJECTION SITE PRESSURE EVERY TIME MOVES IT; INJECTION SITE STINGS/BURN; ARM WAS REALLY RED WHERE THE SHOT WAS GIVEN; This spontaneous report received from a patient concerned a 70 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204B21A expiry: 10-MAY-2022) dose was not reported, administered on 14-SEP-2021 for covid-19 prophylaxis. Age at time of vaccination 70 years old. No concomitant medications were reported. On 14-SEP-2021, the patient experienced arm was really red where the shot was given. On 2022, the patient experienced 2 inch circle that is darker where the vaccine was given, injection site pressure every time moves it, and injection site stings/burn. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from 2 inch circle that is darker where the vaccine was given, injection site stings/burn, and injection site pressure every time moves it, and the outcome of arm was really red where the shot was given was not reported. This report was non-serious.
Patient Pfizer 0.3ml 5/26/21 Lot No.EW0175 CLINIC: (I couldn't figure out how to fill this out on a phone and don't have access to a computer at the moment this is all the info I know about and is all that is listed on the vaccine card.) I received one dose and am not getting the second because of heart pain and more frequent migraines.
Friday 08/20 Nausea dizziness 30 minutes after vaccine given . Later that evening right arm pain. 08/21 Next day sore arm, bodyaches and headache. 08/22 bodyache, mild shortness of breath when walking. 08/23 again mild shortness of breath off and on. 08/24 sob subsided. 08/25 sob is mild to moderate with HR 110 with mild movement. I've been using my albuterol inhaler as needed to help.
Fever 102F  with rash on 04/27/05. Presented @ office 04/29/05 with multiple discrete red papules on trunk and vesicles. 2x3cm red induration on R anterior thigh.
12/21 onset 3 days ago rash, redness, swelling. No rash noted in physical exam.
1.  Horrible tinnitus - will try taking Medrol Pack 2.  Large bumps on tongue - no treatment